Publications

2014

• Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistanceChatzigeorgiou, A., Seijkens, T., Zarzycka, B., Engel, D., Poggi, M., Van Den Berg, S., Van Den Berg, S. & 29 others, 18 Feb 2014, In: Proceedings of the National Academy of Sciences of the United States of America : PNAS. 111, 7, p. 2686-2691, 6 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article

2013

• The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistancePhieler, J., Chung, K. J., Chatzigeorgiou, A., Klotzsche-Von Ameln, A., Garcia-Martin, R., Sprott, D., Moisidou, M. & 11 others, 15 Oct 2013, In: Journal of Immunology. 191, 8, p. 4367-4374, 8 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article
• The role of the complement system in metabolic organs and metabolic diseasesPhieler, J., Garcia-Martin, R., Lambris, J. D. & Chavakis, T., Feb 2013, In: Seminars in Immunology. 25, 1, p. 47-53, 7 p.Electronic (full-text) versionResearch output: Contribution to journal > Review article
• CD40L stimulates the crosstalk between adipocytes and inflammatory cellsChatzigeorgiou, A., Phieler, J., Gebler, J., Bornstein, S. R. & Chavakis, T., 2013, In: Hormone and Metabolic Research. 45, 10, p. 741-747, 7 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article